Sector
PharmaceuticalsOpen
₹1,070.1Prev. Close
₹1,069.6Turnover(Lac.)
₹9,188.68Day's High
₹1,070.8Day's Low
₹1,039.252 Week's High
₹1,59252 Week's Low
₹1,010Book Value
₹375.96Face Value
₹1Mkt Cap (₹ Cr.)
61,060.66P/E
30.87EPS
33.74Divi. Yield
030 Jul 2024
12:00 AM
AGM
Announcement Date: 30 Jul, 2024
23 Jul 2025
12:00 AM
Board Meeting
Agenda : Audited Result
The company announced an operating EBITDA of ₹1,603 Crore, registering a marginal decline of 1% year-on-year.
Here are some of the stocks that may see significant price movement today: LTIMindtree, Paytm, Aurobindo Pharma, etc.
Lannett is a legacy pharmaceutical firm founded in 1942. It is headquartered in Trevose, Pennsylvania, brings with it a deep expertise in manufacturing complex generics.
Here are some of the stocks that may see significant price movement today: FSN E-Commerce, Voltas Limited, Aurobindo Pharma, etc.
Dyrupeg is used primarily to reduce the risk of infection in cancer patients undergoing chemotherapy.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 58.59 | 58.59 | 58.59 | 58.59 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 19,664.23 | 17,975.44 | 17,058.75 | 15,866.02 |
Net Worth | 19,722.82 | 18,034.03 | 17,117.34 | 15,924.61 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 11,287.14 | 15,823.68 | 13,266.48 | 10,269.9 |
yoy growth (%) | -28.66 | 19.27 | 29.17 | 6.89 |
Raw materials | -5,846.25 | -7,244.82 | -6,523.53 | -4,562.81 |
As % of sales | 51.79 | 45.78 | 49.17 | 44.42 |
Employee costs | -1,600.04 | -1,735.42 | -1,561.47 | -1,131.64 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 1,712.19 | 4,193.01 | 2,377.7 | 2,342.94 |
Depreciation | -415.26 | -488 | -470.48 | -354.83 |
Tax paid | -182.77 | -1,080.1 | -504.96 | -530.17 |
Working capital | -1,929.49 | 771.58 | 1,700.35 | 1,554.63 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -28.66 | 19.27 | 29.17 | 6.89 |
Op profit growth | -64.23 | 53.39 | 0.58 | 12.47 |
EBIT growth | -59.04 | 61.21 | 9.29 | 7.73 |
Net profit growth | -53.26 | 66.22 | 3.3 | 6.21 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 31,378.13 | 28,704.5 | 24,617.13 | 23,366.55 | 24,557.95 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 31,378.13 | 28,704.5 | 24,617.13 | 23,366.55 | 24,557.95 |
Other Operating Income | 345.6 | 297.37 | 238.25 | 88.94 | 216.68 |
Other Income | 621.85 | 557.38 | 290.59 | 320.35 | 3,195.42 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,598.4 | 77.01 | 3,83,569.68 | 753.53 | 1 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,131.5 | 69.69 | 1,62,807.9 | 557 | 0.49 | 2,357 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,596.7 | 61.23 | 1,21,728.28 | 551 | 0.17 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,491 | 23.32 | 1,20,468.02 | 1,303.13 | 1.07 | 4,501.66 | 397.39 |
Mankind Pharma Ltd MANKIND | 2,537.8 | 57.97 | 1,04,911.52 | 412.76 | 0 | 2,541.36 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Vice Chairman & Managing Director
Kambam Nityananda Reddy
Whole-time Director
M Madan Mohan Reddy
Non Executive Director
P V Ramprasad Reddy
Independent Director
Savita Mahajan
Independent Director
Girish Paman Vanvari
Non Executive Director
P Sarath Chandra Reddy
Independent Director
Santanu Mukherjee
Independent Director
Deepali Pant Joshi
Chairman & Independent Director
M R Kumar
Non Executive Director
Satakarni Makkapati
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Telangana - 500038
Tel: 91-40-23736370
Website: http://www.aurobindo.com
Email: cs@aurobindo.com; investorgrievances@aurobindo.com
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K...
Read More
Reports by Aurobindo Pharma Ltd
What is the Aurobindo Pharma Ltd share price today?
What is the Market Cap of Aurobindo Pharma Ltd?
What is the PE and PB ratio of Aurobindo Pharma Ltd?
What is the 52 Week High and Low of Aurobindo Pharma Ltd?
What is the CAGR of Aurobindo Pharma Ltd?
What is the shareholding pattern of Aurobindo Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
